NCT06442111View on ClinicalTrials.gov

The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy

NANot yet recruitingINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Pancreaticojuodenectomy

Interventions

DRUG

The intravenous ferritin group

Administer intravenous ferritin approximately 3-7 days before surgery (0.9% normal saline 250ml + 1000 mg of ferric carboxymaltose \[Ferinject™, Vifor Pharma, Glattbrugg, Dwitzerland\], inject over 15 minutes)

DRUG

The placebo group

Administer intravenous 10ml of normal saline (Isotonic Sodium Chloride Injection Daihan(50mL/bag)) approximately 3-7 days before surgery

All Listed Sponsors

lead

Seoul St. Mary's Hospital

OTHER

NCT06442111 - The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy | Biotech Hunter | Biotech Hunter